Proskauer advised Cohere Capital Partners on the deal. Cohere Capital Partners (“Cohere”) announced the closing of Cohere Capital Fund II (“Fund II”) with more than $215...
You must be a Standard 1 Year member to access this content.
Proskauer advised Glouston Capital Partners on the deal. Glouston Capital Partners (“GCP”), a Boston-based independent private equity manager, announced the launch of its seventh flagship secondaries...
You must be a Standard 1 Year member to access this content.
Proskauer represented Flagship Pioneering in the transaction. Flagship Pioneering (“Flagship”), a bioplatform innovation company, raised an additional $3.6 billion of capital to fund the creation and...
You must be a Standard 1 Year member to access this content.
Proskauer advised Harbour Group on the transaction. Harbour Group announced the formation of a $425 million multi-asset continuation fund. The deal was comprised of seven interests held...
You must be a Standard 1 Year member to access this content.
Proskauer advised Long Ridge Equity Partners on the deal. Long Ridge Equity Partners (“Long Ridge”) announced the first and final closing of Long Ridge Equity Partners...
You must be a Standard 1 Year member to access this content.
Proskauer represented Ridgemont Equity Partners in the transaction. Ridgemont Equity Partners (Ridgemont), a middle market private equity firm, announced the formation of Ridgemont Equity Partners IV...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis counseled Trinity Hunt Partners on the deal, while Proskauer advised Schroders Capital as a lead investor in the Continuation Fund. Trinity Hunt Partners,...
You must be a Standard 1 Year member to access this content.
Walder Wyss, Stephenson Harwood, Proskauer Rose, Mourant Ozannes, Arendt & Medernach, Latham & Watkins, Stephenson Harwood, Gleiss Lutz and Poellath advised DPE on this transaction. Debevoise...
You must be a Standard 1 Year member to access this content.
Proskauer advised Atlas Venture on the deal. Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced the closing of its thirteenth...
You must be a Standard 1 Year member to access this content.
Proskauer advised RA Capital Management on the deal. RA Capital Management, LP, a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and...
You must be a Standard 1 Year member to access this content.
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...
You must be a Standard 1 Year member to access this content.
Proskauer advised Perceptive Advisors on the deal. Perceptive Advisors completed the first and final closing of Perceptive Xontogeny Venture Fund II, LP (“PXV Fund II”) with $515...
You must be a Standard 1 Year member to access this content.
